A Facebook explainer says that as of October 2026 retatrutide remains an investigational drug, not cleared by the FDA for any indication.
Recap by typeshit. Post by Facebook on Facebook.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Medscape covers trevogrumab, which it says reduced muscle loss during GLP-1 treatment and helped with weight regain afterward. Tap through for the trial details.
Dr Kopelman's office says GLP-1 drugs can work well for weight loss, but some patients report hair thinning along the way.
Loading…